Scholars Central

Research articlePublished Aug 2021

Is it Possible to Combine Drugs and To Achieve a Better Antiviral Response against COVID-19?

Authors: Elitsa Gotseva, Elena Filipova, Katya Uzunova, Velichka Pavlova, Silvia Hristova, Toni Vekov

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

COVID-19 caused global pandemic with no specific treatment available so far. Developing new drugs usually requires time and is impractical to meet the immediate global challenge. Repurposing of drugs is a good alternative because these medicines have well established safety and efficacy profile. It is likely to not achieve a significant clinical benefit as a result of using a single drug but a careful well studied combination may lead to a better efficacy. This article emphasizes the potential combination of 3 well known drugs already used as single agents against COVID-19 with contradictory results – Hydroxychloroquine, Ivermectin and Colchicine. We try to give a closer look of their mechanism of action and the possibility to be effective at different stages of the treatment when used in one regimen. Hydroxychloroquine inhibits glycosylation of ACE2 receptors and thereby prevents COVID-19 from binding to the receptor and entering into host cells. It also prevents from conversion of early endosome into late endosome through increase of the pH. Ivermectin inhibits the nuclear transport through IMP α/β1 and prevents the virus RNA from entering into the nucleus. Colchicine with its anti-inflammatory and anti-viral properties may have a potential benefit in severe COVID-19 related to an inhibitory effect on the activation, destabilization, and degradation of inflammasomes. Further investigations followed by well-designed clinical studies of these drugs are recommended before this theory be rejected or confirmed.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Infectious Diseases & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Infectious Diseases & Therapy
  • SubjectInfectious Diseases
  • BylineArticles whose byline prints “Elitsa Gotseva”
  • BylineArticles whose byline prints “Elena Filipova”
  • BylineArticles whose byline prints “Katya Uzunova”
  • BylineArticles whose byline prints “Velichka Pavlova”
  • BylineArticles whose byline prints “Silvia Hristova”
  • BylineArticles whose byline prints “Toni Vekov”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels